Hung Jen Shao
About Hung Jen Shao
Hung Jen Shao serves as the Director of CTC Instrumentation at CellMax Life, where he has worked since 2017. He holds a Doctor of Philosophy from National Taiwan University and has contributed significantly to cancer detection research, particularly in the development of blood tests for early detection of colorectal cancer.
Work at CellMax Life
Hung Jen Shao has been serving as the Director of CTC Instrumentation at CellMax Life since 2017. In this role, he oversees the development and implementation of technologies related to circulating tumor cells. Additionally, he has worked as a Senior Scientist and Lab Specialist at the same organization since 2014. His responsibilities include contributing to the analytical validation of the CellMax platform, which focuses on the early detection of cancer through blood tests.
Education and Expertise
Hung Jen Shao earned his Doctor of Philosophy degree from National Taiwan University, where he studied from 2005 to 2010. His academic background provides a strong foundation in the scientific principles underlying his work in cancer detection and instrumentation. This expertise is reflected in his contributions to research and development in the field of oncology.
Research Contributions
Hung Jen Shao has significantly contributed to the development and clinical validation of blood tests aimed at the early detection of colorectal adenomas and cancer. He has participated in multiple research studies focused on cancer detection and circulating tumor cells, contributing to advancements in the field. His work has been recognized through presentations at major conferences, including the ASCO Gastrointestinal Cancers Symposium and Digestive Disease Week.
Publications and Presentations
Hung Jen Shao has co-authored several publications in reputable journals, including the Journal of Circulating Biomarkers and Clinical and Translational Gastroenterology. His research findings have been presented at significant conferences, showcasing his contributions to the field of cancer detection and circulating tumor cells. These publications and presentations highlight his commitment to advancing knowledge in oncology.